Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis

Author： O’Doherty Catherine Schnabl Matthew Spargo Llewellyn Cleland Leslie G James Michael Proudman Susanna M Wiese Michael D

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.12, 2012-09, pp. : 1427-1434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne Dougados Maxime

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A. Emery P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide for the Treatment of Rheumatoid Arthritis in Clinical Practice: Incidence and Severity of Hepatotoxicity

By van Roon E.N. Jansen T.L.T.A.

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 345-352

Adis International

Access to resources Recommend Favorite

Safety evaluation of leflunomide in rheumatoid arthritis

By I Keen Helen

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 581-588

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide in Combination Therapy for Rheumatoid Arthritis

By Savage Ruth L.

Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. : 523-526

Adis International

Access to resources Recommend Favorite